Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neutrophil-to-lymphocyte Ratio and CA 19.9 as Predictors of Perineural Invasion in Pancreatic Cancer

NCT06747481 is registered in ClinicalTrials.gov with University of Las Palmas de Gran Canaria as lead sponsor.

NCT NCT06747481
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06747481 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neutrophil-to-lymphocyte Ratio and CA 19.9 as Predictors of Perineural Invasion in Pancreatic Cancer
Lead sponsor
University of Las Palmas de Gran Canaria
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2020
Completion date
September 30, 2025
Enrollment
323 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ca 19.9, neutrophil-to-lymphocyte ratio, pancreatic cancer, adult, perineural invasion